Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $49,825 | 10 | 99.9% |
| Food and Beverage | $34.10 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $37,125 | 8 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $6,850 | 1 | $0 (2022) |
| AIMMUNE THERAPEUTICS, INC. | $5,850 | 1 | $0 (2020) |
| Janssen Research & Development, LLC | $34.10 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $6,850 | 1 | AstraZeneca Pharmaceuticals LP ($6,850) |
| 2021 | $37,125 | 8 | Alexion Pharmaceuticals, Inc. ($37,125) |
| 2020 | $5,850 | 1 | AIMMUNE THERAPEUTICS, INC. ($5,850) |
| 2017 | $34.10 | 1 | Janssen Research & Development, LLC ($34.10) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2022 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $6,850.00 | General |
| 11/19/2021 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,160.00 | General |
| 10/29/2021 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,320.00 | General |
| 08/06/2021 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,455.00 | General |
| 08/05/2021 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $8,100.00 | General |
| 07/30/2021 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,590.00 | General |
| 07/23/2021 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,240.00 | General |
| 05/21/2021 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,400.00 | General |
| 05/07/2021 | Alexion Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,860.00 | General |
| 10/09/2020 | AIMMUNE THERAPEUTICS, INC. | — | Consulting Fee | Cash or cash equivalent | $5,850.00 | General |
| 03/20/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $34.10 | General |
About John Curnutte, M.D., PH.D
John Curnutte, M.D., PH.D is a Pediatric Hematology-Oncology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1215134622.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Curnutte, M.D., PH.D has received a total of $49,859 in payments from pharmaceutical and medical device companies, with $6,850 received in 2022. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($49,825).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Palo Alto, CA
- Active Since 06/29/2007
- Last Updated 07/08/2007
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1215134622
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Palo Alto
Philip Pizzo, Md, MD
Pediatric Hematology-Oncology — Payments: $2.6M
Christopher Dvorak, Md, MD
Pediatric Hematology-Oncology — Payments: $125,679
Bertil Glader, Md, MD
Pediatric Hematology-Oncology — Payments: $47,480
Glaivy Batsuli, Md, MD
Pediatric Hematology-Oncology — Payments: $43,490
Michael Link, Md, MD
Pediatric Hematology-Oncology — Payments: $42,188
Orly Klein, Md, MD
Pediatric Hematology-Oncology — Payments: $31,152